This project investigates a previously unknown function of the blood coagulation regulator Thrombomodulin and the natural protein C pathway in the hematopoietic stress response to radiation-injury and chemotherapy. We found that the endogenous Thbd- protein C pathway is required for the efficient recovery of hematopoiesis after lethal radiation exposure, and that pharmacologic supplementation of protein C pathway function prevents death caused by radiation-induced bone marrow failure. This proposal investigates the cellular and molecular mechanism mediating this newly discovered function of the Thrombomodulin-protein C pathway.
Aim 1 identifies the as yet unknown relevant stromal and hematopoietic cell populations that express Thrombomodulin in normal bone marrow and in bone marrow exposed to myeloablative stress (radiation- injury and chemotherapy).
Aim 2 tests the hypothesis that Thrombomodulin expression in stromal endothelium of the bone marrow is necessary for the normal recovery of hematopoiesis after myelosuppression;and that this effect of Thrombomodulin is based on its ability to augment in an EPCR- and PAR1-dependent manner the tie2- angiopoietin1-mediated recovery of the vascular stem cell niche.
Aim 3 investigates the functional role of Thrombomodulin in hematopoietic stem and progenitor cells. This function is likely different from its role in endothelial cells and may involve the regulationof the supportive function of stromal macrophages in hematopoietic recovery from myelosuppression, as well as the cell-autonomous enhancement of myelopoiesis.
Aim 4 delineates the contributions of aPC's anticoagulant and cell signaling functions to its therapeutic efficacy in supporting hematopoietic recovery from myeloablation. These studies will document a new physiologic connection between blood coagulation and hematopoiesis, and have the potential to significantly impact the current understanding of hematopoiesis and approaches to its pharmacologic manipulation.
This project investigates a newly discovered function of the Thrombomodulin-protein C pathway in the hematopoietic recovery from radiation and chemotherapy. Using mouse models, we investigate the hypothesis that this pathway coordinates the response of stromal and hematopoietic cells comprising the stem cell niche in the bone marrow.
|van Mens, Thijs E; Liang, Hai-Po H; Basu, Sreemanti et al. (2017) Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation. Blood Adv 1:1148-1158|
|Pathak, Rupak; Shao, Lijian; Ghosh, Sanchita P et al. (2015) Thrombomodulin contributes to gamma tocotrienol-mediated lethality protection and hematopoietic cell recovery in irradiated mice. PLoS One 10:e0122511|
|Dinarvand, Peyman; Hassanian, Seyed Mahdi; Weiler, Hartmut et al. (2015) Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation. Blood 125:1339-48|
|Liang, Hai Po H; Kerschen, Edward J; Basu, Sreemanti et al. (2015) Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice. Blood 126:2415-23|
|Liang, Hai Po H; Kerschen, Edward J; Hernandez, Irene et al. (2015) EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. Blood 125:2845-54|
|Kerschen, E; Hernandez, I; Zogg, M et al. (2015) Survival advantage of heterozygous factor V Leiden carriers in murine sepsis. J Thromb Haemost 13:1073-80|
|Jokinen, Riikka; Lahtinen, Taina; Marttinen, Paula et al. (2015) Quantitative changes in Gimap3 and Gimap5 expression modify mitochondrial DNA segregation in mice. Genetics 200:221-35|
|Weiler, Hartmut (2014) Inflammation-associated activation of coagulation and immune regulation by the protein C pathway. Thromb Res 133 Suppl 1:S32-4|